Literature DB >> 26477475

Clinical predictors of prolonged postresection hypotension after laparoscopic adrenalectomy for pheochromocytoma.

Takeshi Namekawa1, Takanobu Utsumi2, Koji Kawamura1, Naoto Kamiya3, Takashi Imamoto1, Tomoko Takiguchi4, Naoko Hashimoto4, Tomoaki Tanaka4, Yukio Naya5, Hiroyoshi Suzuki3, Tomohiko Ichikawa1.   

Abstract

BACKGROUND: Although the perioperative management of patients with pheochromocytoma has been improving recently, severe hypotensive episodes can occur that require postoperative catecholamine support and are challenging to manage. Our aim was to identify the clinical factors that predict prolonged postresection hypotension in patients after laparoscopic adrenalectomy for pheochromocytoma.
METHODS: The records of 73 Japanese patients who underwent unilateral laparoscopic adrenalectomy for pheochromocytoma were surveyed retrospectively. Patients were divided into 2 groups according to whether catecholamine support was needed after postoperatively. Clinical and biochemical data were evaluated at baseline and after operation.
RESULTS: Thirty-four of 73 patients (47%) required continuous infusion of catecholamine to maintain systolic blood pressure >90 mm Hg at the end of the operation. The median duration of postoperative catecholamine support was 17 hours (range, 3-130) in these 34 patients. On multivariate analysis, tumor size >60 mm, urinary epinephrine levels >200 μg/day, and urinary norepinephrine levels >600 μg/day were independent predictors of prolonged hypotension requiring postoperative catecholamine support. Tumor size and urinary norepinephrine levels were significantly correlated with the duration of postoperative catecholamine support.
CONCLUSION: Larger tumor size and greater values of urinary epinephrine and norepinephrine levels were significant predictors of prolonged hypotension requiring postoperative catecholamine support. Moreover, tumor size and urinary norepinephrine levels were positively correlated with the duration of postoperative catecholamine support. Clinicians can identify and manage patients more effectively with a greater risk of prolonged hypotension after tumor resection using these preoperative clinical variables.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26477475     DOI: 10.1016/j.surg.2015.09.016

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  19 in total

1.  Pheochromocytoma surgery without systematic preoperative pharmacological preparation: insights from a referral tertiary center experience.

Authors:  Cyrille Buisset; Carole Guerin; Pierre-Julien Cungi; Mickael Gardette; Nunzia-Cinzia Paladino; David Taïeb; Thomas Cuny; Frederic Castinetti; Frederic Sebag
Journal:  Surg Endosc       Date:  2020-02-18       Impact factor: 4.584

Review 2.  Pheochromocytomas and Hypertension.

Authors:  Joseph M Pappachan; Nyo Nyo Tun; Ganesan Arunagirinathan; Ravinder Sodi; Fahmy W F Hanna
Journal:  Curr Hypertens Rep       Date:  2018-01-22       Impact factor: 5.369

Review 3.  Perioperative hemodynamic instability in patients undergoing laparoscopic adrenalectomy for pheochromocytoma.

Authors:  Magdalena Pisarska; Michał Pędziwiatr; Andrzej Budzyński
Journal:  Gland Surg       Date:  2016-10

4.  Actualities in the anaesthetic management of pheochromocytoma/ paraganglioma.

Authors:  D Godoroja-Diarto; C Moldovan; V Tomulescu
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Oct-Dec       Impact factor: 1.104

5.  Effects of pretreatment with terazosin and valsartan on intraoperative haemodynamics in patients with phaeochromocytoma.

Authors:  Qingrong Ji; Feng Li; Xianzhao Zhang; Yuqiang Wang; Cunfei Liu; Ying Chang
Journal:  Eur J Hosp Pharm       Date:  2020-09-07

6.  PATIENTS' SAFETY AND FEASIBILITY OF INTRAVENOUS URAPIDIL IN THE PRETREATMENT OF PHEOCHROMOCYTOMA PATIENTS IN A NORMAL WARD SETTING - AN ANALYSIS OF 20 CONSECUTIVE CASES.

Authors:  A Reinisch; K Holzer; J Bojunga; W O Bechstein; N Habbe
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Oct-Dec       Impact factor: 0.877

7.  Risk factors of post-operative severe hyperlactatemia and lactic acidosis following laparoscopic resection for pheochromocytoma.

Authors:  Shubin Wu; Weiyun Chen; Le Shen; Li Xu; Afang Zhu; Yuguang Huang
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

Review 8.  Current perioperative management of pheochromocytomas.

Authors:  Rashmi Ramachandran; Vimi Rewari
Journal:  Indian J Urol       Date:  2017 Jan-Mar

9.  Incidence, risk factors and clinical significance of postoperative haemodynamic instability after adrenalectomy for phaeochromocytoma.

Authors:  Joseph P Thompson; Davinia Bennett; James Hodson; Miriam Asia; John Ayuk; Michael W O'Reilly; Niki Karavitaki; Wiebke Arlt; Robert P Sutcliffe
Journal:  Gland Surg       Date:  2019-12

10.  Risk factors for prolonged hypotension in patients with pheochromocytoma undergoing laparoscopic adrenalectomy: a single-center retrospective study.

Authors:  Shubin Wu; Weiyun Chen; Le Shen; Li Xu; Afang Zhu; Yuguang Huang
Journal:  Sci Rep       Date:  2017-07-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.